Risk-based monitoring software provides clinical teams with a single platform that transforms numerous study data streams into actionable analytics.
Risk-based Monitoring Software: Introduction
- Risk-based monitoring software provides clinical teams with a single platform that transforms numerous study data streams into actionable analytics
- The result is a more focused and data driven monitoring effort that enables sponsor oversight and improves the quality and compliance of a clinical trial or program
Read Report Overview - https://www.transparencymarketresearch.com/riskbased-monitoring-software-market.html
Key Drivers of Global Risk-based Monitoring Software Market
- Increasing efficiency and cost of risk-based monitoring solutions and growing investments by governments to support clinical trials owing to its rising demand are key factors driving the risk-based monitoring software market
- Major market players are focusing on the launch of updated versions of risk-based monitoring software, which is likely fuel the demand for risk-based monitoring software in pharmaceutical and biopharmaceutical companies, CROs, medical device companies. For instance, in 2018, Bioclinica launched the SMART technology suite available with Medical Imaging, Electronic Data Capture (EDC) and Interactive Response Technology (IRT) combined.
- However, high cost of implementation of risk-based monitoring solutions is likely to hamper the market during the forecast period
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78515
Enterprise RBM Software Segment to Expand Considerably
- In terms of type, the global risk-based monitoring software market can be divided into Enterprise RBM Software and Site RBM Software
- The Enterprise RBM Software segment accounted for a prominent share of the market, in terms of revenue, in 2019. The segment is anticipated to expand during the forecast period. Enterprise RBM Software provides all authorized professionals access to clinical trial data and metrics placed at a centralized location, which fuels the adoption of Enterprise RBM Software.
Software Segment to Expand Significantly
- In terms of component, the global risk-based monitoring software market can be bifurcated into software and services
- The software segment accounted for a notable share of the global risk-based monitoring software market in 2019. Increase in number of clinical trials, customer base, and R&D expenditure in life science and clinical research industries is expected to drive the segment.
Request for Analysis of COVID-19 Impact on Risk-based Monitoring Software Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78515
Web-based (On-demand) to be Highly Lucrative Segment
- Based on delivery mode, the global risk-based monitoring software market can be classified into Web-based (On-demand), Licensed Enterprise (On-premise), and Cloud-based (SaaS)
- Web-based (on-demand) was a highly lucrative segment, in terms of revenue, in 2019. The trend is likely to continue during the forecast period. Web-based (On-demand) software offers benefits such as improved productivity, easy access, time efficiency, and cost-efficiency, which propel the demand for web-based risk-based monitoring software.
Pharmaceutical and Biopharmaceutical Companies to be Highly Lucrative Segment
- In terms of end-user, the global risk-based monitoring software market can be divided into: pharmaceutical and biopharmaceutical companies, CROs, medical device companies, and others. The pharmaceutical and biopharmaceutical companies segment accounted for a significantly share of the market, in terms of revenue, in 2019. It is anticipated to expand during the forecast period. Increase in R&D expenditure of pharmaceutical and biopharmaceutical companies is likely to fuel the segment during the forecast period.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=78515
North America to Dominate Global Risk-based Monitoring Software Market
- In terms of region, the global risk-based monitoring software market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominated the global risk-based monitoring software market in 2019. The trend is projected to continue during the forecast period. The region’s dominance can be attributed to an increase in government funding for clinical trials, presence of major players, and well-established healthcare system.
- The risk-based monitoring software market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period owing to an increase in the demand for technologically advanced risk-based monitoring software in developing countries, such as India and China, in the region
Pre Book Risk-based Monitoring Software Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=78515<ype=S
Key Players Operating in Global Risk-based Monitoring Software Market
The global risk-based monitoring software market was highly fragmented in 2019.
More Trending Reports by Transparency Market Research:
Implantable Medical Devices Market According to Transparency Market Research’s latest report on the global Implantable Medical Devices market for the historical period 2017–2018 and forecast period 2019–2027. Increase in prevalence of coronary arterial diseases (CADs), rise in demand for minimally invasive procedures and rise in geriatric population are projected to drive the global market during the forecast period.
Pericardiocentesis Procedures Market Several methods are being used for the treatment of pericardial effusion (PE) in the pericardiocentesis procedures market. As such, there is a growing awareness about echocardiography (ECHO) as one of the most valuable tools for assessing PE. M-mode ECHO is advantageous to detect even a small amount of fluid accumulated in the pericardium sac around the heart.
Non-Invasive Prenatal Testing Market Increasing maternal age is one of the main reasons behind growing cases of children born with chromosomal abnormalities such as Down syndrome and Tuner’s syndrome. Non-invasive prenatal diagnostics enable medical professionals to diagnose such condition beforehand.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/